UK approves Pfizer jab for use in 12-15-year-olds
- 3 years ago
- International
The UK has approved the use of the Pfizer-BioNTech vaccine in children aged 12-15, saying it is safe and effective in this age group and the
Breaking News
BioNTech
-
-
Pfizer, BioNTech seek U.S. emergency nod for COVID-19 vaccine in adolescents
- 3 years ago
- International
Pfizer Inc and its German partner BioNTech SE said on Friday they have requested the U.S. Food and Drug Administration to expand the emergency use
-
-
Pfizer, BioNTech launch COVID-19 vaccine trial in kids under 12
- 3 years ago
- Health
Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that
-
-
Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study
- 3 years ago
- International
The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil,
-
-
Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo
- 3 years ago
- Updates
Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first
-
-
Ministry of Public Health Issues Emergency Use Authorization for Pfizer and BioNTech's COVID-19 vaccine
- 3 years ago
- Local
In implementation of the directives of His Highness The Amir Sheikh Tamim bin Hamad Al Thani regarding the arrival of the first shipment of the
-
-
UK starts covid vaccination, 90-year-old Keenan gets first Pfizer shot
- 3 years ago
- Updates
I feel so privileged to be the first person vaccinated against Covid-19, said Margaret Keenan Keenan received the jab at her local
-
-
MOPH’s proactive approach to securing a COVID-19 vaccine is proving effective
- 3 years ago
- Local
A United States biotech company, that interim data from its ongoing trials shows its COVID-19 vaccine is 95 percent effective, Dr. Abd
-
-
BioNTech says vaccine approval possible in mid-December under ideal conditions
- 3 years ago
- Updates
REUTERS
U.S. and European regulators could approve Pfizer and BioNTech’s experimental COVID-19 vaccine as early as mid-December,
-
-
Man behind Pfizer/BioNtech vaccine says it can end pandemic
- 3 years ago
- Updates
BioNTech’s CEO Ugur Sahin says he is confident vaccine can ‘bash the virus over the head’.
The man behind the first
-
-
Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteers
- 4 years ago
- Updates
REUTERS
Pfizer Inc and BioNTech SE on Saturday proposed to the U.S Food and Drug Administration (FDA) to expand their Phase 3 pivotal
-
-
Pfizer Vaccine Deal at $20 a Dose Sets Ceiling for Rivals
- 4 years ago
- Updates
By James Paton, Riley Griffin, and Robert Langreth,
Loading more postNews
Blog
-
Which Jacket Type Fits Your Personality?
- 3 years ago
-
Things to do this weekend: July 15 - 17
- 3 years ago
